DANIELLE MONDELLO: Open Payments
NPI 1265192058 · MATAWAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 24 payments from 13 companies in 2025. Trend: 2023 $563 · 2024 $676 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 4 | $69 |
| PFIZER INC. | 3 | $62 |
| Galderma Laboratories, L.P. | 2 | $34 |
| Arcutis Biotherapeutics, Inc. | 2 | $33 |
| STRATA Skin Sciences, Inc. | 2 | $25 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $25 |
| Kerecis Limited | 1 | $24 |
| LEO Pharma Inc. | 1 | $20 |
| Organon LLC | 1 | $18 |
| UCB, Inc. | 1 | $18 |
Products named: SOFDRA, CIBINQO, NEMLUVIO, Zoryve, XTRAC, Kerecis SurgiClose, ANZUPGO, VTAMA.
Industry payments across NJ — which companies pay providers there.
